FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/071502 [Registered on: 29/07/2024] Trial Registered Prospectively
Last Modified On: 23/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To evaluate effect of daruharidra arka in the management of dry eye syndrome  
Scientific Title of Study   Effect of daruharidra arka in the management of dry eye syndrome- a randomized control trial  
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vignesh Sen 
Designation  Pg Scholar  
Affiliation  Amrita vishwa vidyapeetham 
Address  Department of rasasastra and bhaishajya kalpana, Amrita school of ayurveda Amritapuri, Clappana po Kollam

Kollam
KERALA
690525
India 
Phone  8921769438  
Fax    
Email  vigneshsen77@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Vineeth P K 
Designation  Associate Professor, Department of rasasastra and bhaishajya kalpana 
Affiliation  Amrita vishwa vidyapeetham 
Address  Department of rasasastra and bhaishajya kalpana, Amrita school of ayurveda Amritapuri, Clappana po Kollam

Kollam
KERALA
690525
India 
Phone  8547483357  
Fax    
Email  dr.vineethpk@ay.amrita.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Vineeth PK 
Designation  Associate Professor, Department of rasasastra and bhaishajya kalpana 
Affiliation  Amrita vishwa vidyapeetham 
Address  Amrita school of ayurveda Amritapuri, Clappana po Kollam,Kerala,India- 690525

Kollam
KERALA
690525
India 
Phone  8547483357  
Fax    
Email  dr.vineethpk@ay.amrita.edu  
 
Source of Monetary or Material Support  
Amrita school of ayurveda Amrita vishwa vidyapeetham,Amritapuri campus, Clappana PO Kollam-690525,Kerala,India  
 
Primary Sponsor  
Name  Dr Vignesh Sen 
Address  Amrita school of ayurveda Amrita vishwa vidyapeetham,Amritapuri campus, Clappana PO Kollam-690525,Kerala,India  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vignesh Sen  Amrita School Of Ayurveda  Department of rasasastra and bhaishajya kalpana Amrita school of ayurveda Amritapuri, Clappana po Kollam, Kerala, 690525
Kollam
KERALA 
8921769438

vigneshsen77@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC Amrita School Of Ayurveda  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H048||Other disorders of lacrimal system. Ayurveda Condition: SUSHKAKSHIPAKAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-AScyotanam, आश्च्योतनम् (Procedure Reference: Susrutha (Su.U. 18/45-46), Procedure details: (2 drops) two times a day for a duration of one month )
(1) Medicine Name: Daruharidra arka, Reference: Arkaprakasha, Route: Ocular, Dosage Form: Arka, Dose: 2(drops), Frequency: bd, Duration: 1 Months
2Comparator Arm (Non Ayurveda)-Carboxymethylcellulose2 drops two times a day for a duration of one month
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  1.Patient having specific symptoms of Dry eye.
2.Schirmer-I test positive (less than 15mm)
3.Tear film break-up time less than 15 seconds
 
 
ExclusionCriteria 
Details  1.Patient with impaired eyelid function (eg: Bell’s palsy)
2.Patients with eyelid deformities
3.Patients with infective eye disease
4.Pregnancy, lactation, patients under corticosteroids
5.Patients on steroids, oral contraceptive pills, estrogen replacement therapy or any other medication that may adversely affect the outcome of the study
6.Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuro- Endocrinal disorders, etc.).


 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Reduction in pain, sensitivity, Blurred vision
Improvement in schimers test and Tear film breakup time
 
4 weeks and 8 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Reduces the discomfort in eye  4 weeks & 8 weeks 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   30/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="5"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

SUMMARY OF PROPOSED DISSERTATION EFFECT OF DARUHARIDRA ARKA IN THE MANAGEMENT OF DRY EYE SYNDROME - A RANDOMIZED CONTROL TRIAL 

GUIDE – Dr VINEETH P K, CO- GUIDE – Dr PRAJEESH NATH E N, SCHOLAR – Dr VIGNESH SEN 
In ophthalmology, Dry Eye Syndrome is a common issue, corresponds to the traditional Ayurvedic concept of “Sushkakshipaka”. This condition is characterized by inadequate tear production, resulting in a lack of proper lubrication and nourishment for the eyes.Tears play a vital role in maintaining the cornea’s health and ensuring clear vision. Dry eye is a chronic concern, especially among the elderly, and is influenced by various factors such as ageing, medical conditions, medicine side effects, dry climates and increased screen time.In the previous studies carried out in various countries estimate the prevalence of dry eye disease to be between 5-34 %, while India is at 29.25%. Despite the vital significance of maintaining vision and the prevalence of Dry Eye Syndrome, effective treatment solution remains limited. Traditional Ayurvedic texts provide comprehensive guidance on the management of Sushkakshipaka. Arka kalpana are mentioned for the management of eye diseases. It has more shelf life, increased potency, and it is laghupaki, vyavayi and vikasi. Daruharidra arka used in this study has the properties like chakshushya, netraruja-hara, sodhahara, kanduhara, ropana. According to Susruta samhita considered Shushkakshipaka is due to due to excessive vitiation of vata. And Ashtanga Hridaya has attributed involvement of vata and pitta doshas in the pathogenesis In a recent study on dry eye management, Daruharidradi seka shows promising results in relieving ruksha, toda, raga, and daha. The ushna virya of Daruharidra helps to pacify the Vata dosha making way for samprapti vighatana and relieving symptoms. Based on this, here we are using Daruharidra arka in the management of dry eye. Carboxymethylcellulose eye drops is taken as the control group in this study. The clinical study will be carried out in 40 patients (20 patients in two groups by lot or chit method) with signs and symptoms of Dry Eye Syndrome who fulfil inclusion criteria belonging to either sex from OPD and IPD of Amrita School of Ayurveda Clinical assessment is done using subjective parameter Ocular Surface Disease Index (OSDI) Questionnaire. And Objective Parameters is done using Tear film break up time,Schirmer test 1 Consent will be taken in their own language before treatment. Subjective and objective parameters will be assessed and recorded in CRF. To group A Aschyotana is done with Daruharidra arka (3 drops) two times a day for a duration of one month. For group B Aschyotana is done with Carboxymethylcellulose eye drops (3 drops) two times a day for a duration of one month. After treatment both subjective and objective parameters will be assessed and recorded. Follow on 15th day after the treatment to assess the sustained effect of the treatment. The data obtained will be tabulated and statistically analysed using Wilcoxon signed rank test and Paired-t-test
 
Close